• Savewith a NBCUniversal ProfileCreate your free profile or…
  • Oct. 11, 2025, 8:00 AM EDTBy Alicia Victoria…
  • Palestinians Begin Return Home As Ceasefire Takes Effect
  • Oct. 11, 2025, 8:48 AM EDT / Updated Oct. 11, 2025,…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Chinese spy balloon was able to transmit information back to Beijing

admin - Latest News - September 22, 2025
admin
22 views 5 mins 0 Comments



Washington
CNN
 — 

The Chinese spy balloon that transited the US earlier this year was able to capture imagery and collect some signals intelligence from US military sites, a source familiar with the matter tells CNN.

The balloon was able to transmit information back to Beijing in real time, the source said, and the US government still does not know for sure whether the Chinese government could wipe the balloon’s data as it received it. That raises questions about whether there is intelligence the balloon was able to gather that the US still doesn’t know about.

Still, the intelligence community has not been overly concerned about the information the balloon was able to gather, the person said, because it is not much more sophisticated than what Chinese satellites are able to glean as they orbit over similar locations.

A US intelligence official told CNN on Monday that “although analysis of the wreckage of the High Altitude Balloon remains ongoing, thus far, its flight over the United States does not appear to have provided critical new insights to the People’s Republic of China.”

The US also knew what the balloon’s path would be and was able to protect sensitive sites and censor some signals before the balloon was able to pick them up, officials have said.

As CNN has reported, the US intelligence community last year developed a method of tracking what it says is a fleet of these Chinese balloons operating across the globe, controlled by the Chinese military.

The FBI is still examining the balloon, but so far officials have been able to glean additional information about how the device worked, including the algorithms used for the balloon’s software and how it is powered and designed.

CNN has reached out to the National Security Council at the White House and the Pentagon for comment. NBC was first to report on the new intelligence.

Justin Trudeau

Justin Trudeau on what the world needs to do to handle China’s threats

Justin Trudeau on what the world needs to do to handle China’s threats

01:33

The balloon first crossed into US airspace over Alaska in late January before passing through Canada and down into Montana, where it hovered for a few days, leading the US to believe it was trying to surveil sensitive military sites, like Malmstrom Air Force Base in Montana. It was eventually shot down by the US off the East Coast on February 4, and the incident further escalated tensions between Washington and Beijing, including the postponement of a diplomatic visit by US Secretary of State Antony Blinken to China.

A senior State Department official said in February that, as the balloon floated across the US, it “was capable of conducting signals intelligence collection operations.”

Gen. Glen VanHerck, the commander of US Northern Command and NORAD, said at the time that the US “did not assess” that the balloon “presented a significant collection hazard beyond what already exists in actionable technical means from the Chinese.”

The surveillance program, which includes a number of similar balloons, is in part run out of the small Chinese province of Hainan, officials told CNN. The US does not know the precise size of the fleet of Chinese surveillance balloons, but sources tell CNN that the program has conducted at least two dozen missions over at least five continents in recent years.

Roughly half a dozen of those flights have been within US airspace, although not necessarily over US territory, according to one official familiar with the intelligence.

China has maintained that the balloon was actually just a weather balloon thrown off course, and the US has been assessing the possibility that it was not deliberately maneuvered into the continental US by the Chinese government, CNN has reported.

Still, China did maintain some ability to maneuver the balloon, officials believe. And once the balloon was over Montana, China appeared to take advantage of its position to loiter over sensitive sites and try to collect intelligence.

This story has been updated with additional reporting.



Source link

TAGS:
PREVIOUS
Wall Street Journal reporter Evan Gershkovich appeals against arrest, Russian state media says
NEXT
Inside haggis: The secrets of Scotland’s national dish
Related Post
October 4, 2025
Illinois Gov. JB Pritzker says Trump is set to federalize the state's National Guard
September 26, 2025
Sept. 26, 2025, 11:24 AM EDTBy Rob Wile and Steve KopackAnalysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to impose on drug product imports as soon as next week.But a series of exemptions may blunt the ultimate impact. In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S. would face a 100% tariff starting Oct. 1.U.S. imports of pharmaceuticals totaled about $213 billion in 2024, a threefold increase from a decade earlier, according to data from the United Nations Comtrade Database.With Asia alone accounting for just over 20% of those imports by value, U.S. consumers could see a “meaningful commercial hit,” Louise Loo, head of Asia economics at Oxford Economics research group, said in a note to clients. Previous studies have shown that U.S. annual spending per capita on prescription drugs is about double the rest of the developed world. In July, Trump announced a plan to “get Americans the best prices in the world for prescription drugs” that involved asking major drugmakers to match low prices they offer elsewhere in the world. However, it is not clear what actions the pharma firms have taken to begin addressing that demand. The pharmaceutical industry is already warning that the new tariffs could derail further drug development while also raising prices. “Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Alex Schriver, senior vice president for PhRMA, the drug industry’s primary lobbying group, said in a statement. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”Despite those warnings, a significant share of drug products could wind up being exempted from the new import duties. The tariffs do not appear to apply to so-called generic drugs, which account for 9 out of 10 prescriptions filled in the U.S., according to the Food and Drug Administration. The White House did not immediately respond to a request to confirm the exemption for generics, but assuming they will remain tariff-free, the impact to consumers could be more limited than feared. Trump also specified that any drug companies that currently have, or have committed to building, U.S.-based drug-making facilities would be exempted from tariffs. That’s a category that includes numerous major drugmakers. “Many pharmaceutical companies have facilities in the U.S., so it may be relatively easy to superficially expand those facilities to avoid tariffs being applied,” Paul Donovan, chief global economist at UBS Global Wealth Management, wrote in a note to clients. Analysts at JPMorgan agreed: “While there remains very limited details, we note that this will likely lead to a majority of pharma products being excluded from any tariffs” because most major companies have recently increased or have started to increase their U.S. manufacturing facilities.On the White House website, the administration maintains a “running list of new U.S. investment” from private companies. At least 15 pharmaceutical or drug makers are listed with investments ranging from new manufacturing facilities, tens of billions in expanded U.S. production and increased R&D spending. Many of those announcements would appear to meet the requirements laid out by Trump to avoid the new tariff.Two major European drugmakers, Roche and Novartis, said in statements that they expected little to no impact from the newly announced duties. “We are working to ensure that all major Novartis medicines for U.S. patients are manufactured in the U.S.,” Novartis said in a statement. “The announced 100% tariff should not have an impact.” Roche pointed to ongoing factory construction in the U.S., with multiple sites being expanded and upgraded in Kentucky, Indiana, New Jersey and California.Trump has signaled since at least April that drug imports would face tariffs. In anticipation, major drugmakers have indicated they have been stockpiling supplies, analysts said. As a result, consumers are unlikely to feel immediate effects even though the tariffs are set to kick in next week. “We think there may have been significant inventory accumulation this year,” Neil Shearing, group chief economist with Capital Economics, said in a note. This summer, Trump placed a maximum 15% tariff on most pharmaceuticals coming in from the European Union, which accounts for 60% of drugs imported by the U.S. E.U. officials believe that this agreement will shield it from the 100% duties, though they said they could not be certain. “This clear all-inclusive 15% tariff ceiling for E.U. exports represents an insurance policy that no higher tariffs will emerge for European economic operators,” a European Commission spokesperson told NBC News on Friday.Ireland’s deputy prime minister, Simon Harris, who also acts as trade minister, said his country is “studying the impact of this announcement” but added that he believed the 15% cap on pharma tariffs remained in place. Ireland alone accounts for 24% of pharma imports to the U.S.Rob WileRob Wile is a Pulitzer Prize-winning journalist covering breaking business stories for NBCNews.com.Steve KopackSteve Kopack is a senior reporter at NBC News covering business and the economy.
October 5, 2025
Trump blasts judge for blocking use of National Guard
October 8, 2025
Authorities announce arrest in California's Palisades Fire
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved